Clinical-stage Firms Present at Health Conference

Several clinical-stage biotechnology and biopharmaceutical companies will participate in the 7th Annual Evercore HealthCONx Conference from December 3-5, 2024, focusing on innovative treatments for various medical conditions. Aura Biosciences will showcase its precision therapies for solid tumors, particularly its lead candidate, AU-011, during a fireside chat on December 3 at 2:35 p.m. ET. Third Harmonic Bio will present its novel small-molecule inhibitors for inflammatory diseases on December 4 at 9:35 a.m. ET, while Coya Therapeutics will discuss its Treg-enhancing biologics on the same day at 12:55 p.m. ET. Contineum Therapeutics, also participating on December 4 at 11:15 a.m. ET, aims to highlight its oral small molecule therapies targeting neuroscience and immunology indications. Live webcasts for these events will be available on each company's website, with replays accessible for 90 days.